Is Harvard Bioscience Inc (NASDAQ: HBIO) Back In The Buying Zone?
Currently, there are 44.21M common shares owned by the public and among those 37.41M shares have been available to trade. The company’s stock has a 5-day price change of 20.58% and -50.56% over the past three months. HBIO shares are trading -80.79% year to date (YTD), with the 12-month market performance down to -86.92% lower. […]
Technical Outlook And Game Plan For Harvard Bioscience Inc (NASDAQ: HBIO)
Harvard Bioscience Inc (HBIO) concluded trading on Thursday at a closing price of $0.67, with 630.81 million shares of worth about $422.64 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -70.48% during that period and on May 29, 2025 the price saw a […]
Is Harvard Bioscience Inc (NASDAQ: HBIO) Back In The Buying Zone?
Currently, there are 44.21M common shares owned by the public and among those 37.43M shares have been available to trade. The company’s stock has a 5-day price change of 6.73% and -75.03% over the past three months. HBIO shares are trading -83.31% year to date (YTD), with the 12-month market performance down to -90.43% lower. […]